Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

uBeAt-powered closed-loop sTandardisaTion of beatIng heart-on-chip for reliable cardioTOxicity screening

Obiettivo

Drug-induced cardiotoxicity remains a primary cause of late-stage clinical attrition. Current preclinical safety assessments are focused heavily on electrophysiology assays and animal models and shows limited predictivity for human outcomes, largely failing to detect critical cardiac liabilities.
Heart-on-Chip models represent a transformative New Approach Methodology (NAM) to address this gap. However, their routine industrial adoption is severely hindered by biological variability and a lack in standardisation. Current Heart-on-Chip models undergo open-loop, fixed maturation protocols (e.g. via electro/mechanical training), resulting in high sample-to sample variability which creates baseline noise that obscures subtle toxicological signals.
BATTITO aims to demonstrate the industrial feasibility of transforming our validated beating heart-on-chip (uHeart) into a self-standardising cardiac NAM. The platform relies on the proprietary uBeat technology, a breakthrough actuator patented by Politecnico di Milano (POLIMI) and licensed to BiomimX, which provides heartbeat like training to cardiac cells. Building on the findings of the ERC Starting Grant EvOoC, which demonstrated that mechanobiological closed-loop feedback enhances tissue maturation, BATTITO will engineer an automated quality loop directly linking optical contractility readouts to the uBeat actuation controller. This autonomous adaptation of the training mechanical forces using the real-time functional state of each individual microtissue will force biological convergence toward a highly standardised functional window.
POLIMI will lead the complex mechatronic integration and the quantitative biological validation of standardisation metrics. Simultaneously, the industrial stakeholder BiomimX will execute market analysis, validate the workflow against industrial constraints, and draft the commercial exploitation roadmap.
BATTITO will deliver an automated NAM platform for robust cardiotoxicity screening.

Campo scientifico (EuroSciVoc)

Questo progetto non è ancora stato classificato con EuroSciVoc.
Suggerisci i campi scientifici che ritieni più rilevanti e aiutaci a migliorare il nostro servizio di classificazione.

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2026-POC

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

POLITECNICO DI MILANO
Contributo netto dell'UE
€ 75 000,00
Indirizzo
PIAZZA LEONARDO DA VINCI 32
20133 Milano
Italia
Regione
Nord-Ovest Lombardia Milano
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato

Beneficiari (2)